MENU
Advertisement
July 16, 2026
ElectroWire’s LightningWire Transseptal Puncture System Receives FDA Clearance
July 16, 2026—ElectroWire Medical announced that the FDA has granted 510(k) clearance for its LightningWire transseptal puncture system, which is indicated to create an atrial septal defect in the heart, whereby various cardiovascular catheters are introduced.
Read Article
News | July 16, 2026Jul162026
News | July 14, 2026Jul142026
Immediate Adoption of Enhanced Radiation Protection in Catheterization Labs Recommended in Multisociety Statement
July 14, 2026—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement on radiation protection in catheterization labs was published by David G. Rizik, MD, et al in JSCAI.
News | July 13, 2026Jul132026
Stereotaxis Completes Acquisition of Robocath
July 13, 2026—Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer of robotic technologies for interventional cardiology and neurointerventions.
News | July 10, 2026Jul102026
First Patient Enrolled in ENHANCE EFS of Nyra’s Carlen TMVR System for FMR
July 10, 2026—Nyra Medical, Inc. announced enrollment of the first patient in the ENHANCE early feasibility study (EFS) of the company’s investigational Carlen system.
TRICURE US Pivotal Study Begins for TriCares’ Topaz TTVR System
July 10, 2026—TriCares SAS announced that the first patient has been enrolled and treated in the TRICURE United States investigation device exemption (IDE) pivotal study, which is evaluating the company’s Topaz transcatheter tricuspid valve replacement (TTVR) system in the treatment of tricuspid regurgitation (TR).
News | July 9, 2026Jul092026
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in PAD and Type 2 Diabetes
July 6, 2026—Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, amputation, and lower-extremity revascularization compared with metformin among adults with type 2 diabetes and peripheral artery disease (PAD), according to the American Heart Association.
News | July 6, 2026Jul062026
Egg Medical Launches EggNest Complete 2.0 Radiation Protection Device
July 6, 2026—Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch of its next-generation EggNest Complete 2.0 system.
Arizona Enacts Law on Radiation Protection Systems for Health Care Workers
July 6, 2026—A state law addressing the safety of staff in medical procedures involving ionizing radiation, lead aprons, radiation protection systems, and real-time dosimeters was enacted by Arizona Governor Kathy Hobbs on June 19.
Renal Denervation in Prime Time
Inside the rapidly evolving landscape of renal denervation: the business case, the latest evidence, the next frontier, and the controversies still fueling debate.
View Issue
March 30, 2026
TRI-FR Trial Results Demonstrate T-TEER Lowers HF Hospitalizations at 2 Years
April 21, 2026
TECTONIC IDE Trial of Abbott’s Coronary IVL Device Completes Enrollment
April 1, 2026
JenaValve’s Trilogy THV System for Symptomatic, Severe AR Launched in the United States